Gastrointestinal Therapy Agents Use 2

    Basic Details
    Date Posted
    Tuesday, September 23, 2014
    Status
    In progress
    Medical Product
    gastrointestinal therapy agent
    Description

    Summary table assessments of the incident and prevalent use of eleven gastrointestinal therapy agents, aprepitant, fosaprepitant dimeglumine, cimetidine, dexlansoprazole, dicyclomine HCL, lubiprostone, mesalamine, nizatidine, sucralfate, and lansoprazol. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table.  Summary tables are precompiled stratified counts.  Queries were executed in 8/19/2013. This report includes data from 16 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2000 - 2012
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)